Reply to “Standardizing diffusion-weighted imaging in LI-RADS for diagnosis of hepatocellular carcinoma”-Reference-Cited by-同舟云学术

Reply to “Standardizing diffusion-weighted imaging in LI-RADS for diagnosis of hepatocellular carcinoma”

Published:2024-08-02 Issue: Volume: Page:
ISSN:1432-1084
Container-title:European Radiology
language:en
Short-container-title:Eur Radiol

Author:

Cannella Roberto^ORCID,Zins Marc,Brancatelli Giuseppe

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00330-024-10927-w.pdf

Reference10 articles.

1. Scialpi M, Evangelisti A, Shehu K, Comite P, Antogiovanni NG, Scalera GB (2024) Standardizing diffusion-weighted imaging in LI-RADS for diagnosis of hepatocellular carcinoma. Eur Radiol. https://doi.org/10.1007/s00330-024-10925-y

2. Cannella R, Zins M, Brancatelli G (2024) ESR Essentials: diagnosis of hepatocellular carcinoma-practice recommendations by ESGAR. Eur Radiol 34:2127–2139. https://doi.org/10.1007/s00330-024-10606-w

3. American College of Radiology (2024) CT/MRI liver imaging reporting and data system v2018 core. https://www.acr.org/-/media/ACR/Files/RADS/LI-RADS/LI-RADS-2018-Core.pdf. Accessed May 2024

4. Dawit H, Lam E, McInnes MDF et al (2024) LI-RADS CT and MRI ancillary feature association with hepatocellular carcinoma and malignancy: an individual participant data meta-analysis. Radiology 310:e231501. https://doi.org/10.1148/radiol.231501

5. Cannella R, Vernuccio F, Sagreiya H et al (2020) Liver Imaging Reporting and Data System (LI-RADS) v2018: diagnostic value of ancillary features favoring malignancy in hypervascular observations ≥ 10 mm at intermediate (LR-3) and high probability (LR-4) for hepatocellular carcinoma. Eur Radiol 30:3770–3781. https://doi.org/10.1007/s00330-020-06698-9